Nasonex

This page contains recent news articles, when available, and an overview of Nasonex but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.


Overview:

Nasonex
(when available)

Pharmacology and use:
Mometasone is a medium-potency synthetic corticosteroid with antiinflammatory, antipruritic, and vasoconstrictive properties. Corticosteroids have been shown to have a wide range of inhibitory effects on multiple cell types (e.g. mast cells, eosinophils, neutrophils, macrophages and lymphocytes) and mediators (e.g. histamine, eicosanoids, leukotrienes, and cytokines) involved in inflammation and in the asthmatic response. These anti-inflammatory actions of corticosteroids may contribute to their efficacy in asthma and in skin lesions. For the maintenance treatment of asthma as prophylactic therapy in patients 12 years of age and older (as an inhalant). Also used as a cream/ointment for the relief of inflammatory and pruritic manifestations of dematoses.

Mechanism Of Action:
Unbound corticosteroids cross cell membranes and bind with high affinity to specific cytoplasmic receptors. Inflammation is decreased by diminishing the release of leukocytic acid hydrolases, prevention of macrophage accumulation at inflamed sites, interference with leukocyte adhesion to the capillary wall, reduction of capillary membrane permeability, reduction of complement components, inhibition of histamine and kinin release, and interference with the formation of scar tissue. The antiinflammatory actions of corticosteroids are thought to involve phospholipase A2 inhibitory proteins, lipocortins, which control the biosynthesis of potent mediators of inflammation such as prostaglandins and leukotrienes. Mometasone furoate has been shown in vitro to exhibit a binding affinity for the human glucocorticoid receptor which is approximately 12 times that of dexamethasone, 7 times that of triamcinolone acetonide, 5 times that of budesonide, and 1.5 times that of fluticasone.

News Articles on Mometasone

Merck Sues Apotex To Block Generic Nasonex In US >MRK  -  ‎Dec 22, 2009‎
The lawsuit was prompted by Apotex's filing for US Food and Drug Administration approval of a generic version of Nasonex. Apotex, a Canadian generics ... Wall Street Journal

Smart Spending on Cold and Flu Remedies  -  ‎Jan 1, 2010‎
I've been doing netti-pot, humidifier, and tried a round of anti allergy meds for weeks at a time (nasonex, claritan and sungular) and two 7 day regimens of ... New York Times (blog)

Proxy adviser takes Sun's side against Taro; Bristol raises dividend to 32 cents;  -  ‎Dec 22, 2009‎
Novartis Release > Merck's Schering-Plough unit sues generics maker Apotex in an effort to stop a copy of the Nasonex allergy inhaler. ... FiercePharma

What your stuffy nose really means  -  ‎Dec 17, 2009‎
There are other treatment options, such as NASONEX(R), the one prescription nasal spray approved by Health Canada for the treatment of sinusitis. ... PharmaLive.com (press release)

Est-ce une sinusite, un rhume ou une grippe?  -  ‎Dec 17, 2009‎
...recommandé de consulter un médecin qui devra prescrire un corticostéroïde comme Nasonex, un vaporisateur nasal spécialement conçu pour les sinusites. ... Canoë

Sachez ce qui se cache vraiment derrière votre nez  -  ‎Dec 16, 2009‎
Il existe d'autres options thérapeutiques, comme NASONEX(MD), le seul médicament d'ordonnance en vaporisateur nasal qui soit approuvé par Santé Canada pour ... CNW Telbec (Communiqué de presse)

Nasonex encourages allergy sufferers to play a new game  -  ‎Nov 1, 2009‎
Schering-Plough used an online game to promote its Nasonex allergy medication, reminding consumers that allergies happen year-round. ... PRWeek

Merck to complete $41B purchase of Schering-Plough  -  ‎Nov 3, 2009‎
The deal adds allergy drugs Nasonex and Clarinex to Merck's Singulair and its diabetes pill Januvia. It also gives Merck animal and consumer health products ... The Associated Press

How Drug Advertising Restrictions Could Benefit the Industry  -  ‎Nov 5, 2009‎
Canada (where viewers are presumably unaffected by US drug advertising) showed no difference across the launch of three drugs, Nasonex, Enbrel and Zelnorm. BNET

Schering-Plough Corporation Q3 2009 Earnings Call Transcript  -  ‎Oct 22, 2009‎
For example, we achieved 18% sales growth with Remicade, excluding currency, and solid growth of other key products such as Temodar and Nasonex. ... Seeking Alpha (blog)

How Many Of You Would Still Sleep With Wax Antonio Banderas?  -  ‎Oct 30, 2009‎
...wethinks placing Waxderas ever so gently in your bed while playing tthe following Nasonex commercial on loop would be oddly satisfying. ... BestWeekEver.tv (satire)

Tips for the modern motorist  -  ‎Nov 1, 2009‎
Everything connected to civilization is at one time driven from Point A to Point B. Hey, 100-mile-diet, you know that Nasonex you took for your sinusitis? ... Globe and Mail

Glucocorticoid Brings Back Sense of Smell Blown Away by a Cold  -  ‎Oct 19, 2009‎
They were then put on a mometasone nasal inhaler (Nasonex, two puffs per nostril twice daily for four weeks) and randomized to oral prednisolone for two ... MedPage Today

Schering-Plough Reports Financial Results for 2009 Third Quarter  -  ‎Oct 22, 2009‎
Global sales of NASONEX, an inhaled nasal corticosteroid for allergies, increased 3 percent to $266 million in the 2009 third quarter (7 percent operational ... Reuters

Chest pain needs diagnosis  -  ‎Oct 26, 2009‎
I do take Xanax for anxiety, when needed, Zoloft for depression, Astelin and Nasonex nasal sprays for allergies and Restasis for dry eyes. ... Times and Transcript

Merck & Co earnings climb as Januvia and Isentress impress  -  ‎Oct 23, 2009‎
SP sells outside the USA, grew 8% to $608 million, while sales of the anti-allergy medication Nasonex/Asmanex (mometasone) were up 3% at $266 million. ... Pharma Times

US stock market opening report (October 22, 2009, Thursday)  -  ‎Oct 22, 2009‎
Exp. USD 583.5mln, Q3 Nasonex sales USD 266mln vs. Exp. USD 266.0mln and sees Merck merger closing in Q4. (BBG/RTRS) Merck – Q3 adjusted EPS USD 0.92 vs. ... Stock Markets Review

Schering-Plough's Nasonex Risk Rises  -  Mar 21, 2006
Bear Stearns maintained an "underperform" rating on Schering-Plough as the price spread widens between generic and branded versions of Flonase, ... Forbes

Pharma Oversold?  -  Sep 1, 2008
For two drugs, Enbrel and Nasonex, the $194 million and $235 million advertising campaigns had no effect whatsoever. Prescription patterns in both ... Forbes

FDA Approves Once-Daily Asthma Medicine  -  Mar 31, 2005
The active ingredient in Asmanex is mometasone furoate, which is used in another form in the prescription nasal allergy spray called Nasonex, also made by ... FOXNews

Schering-Plough profit jumps with help from Remicade, Nasonex.  -  Jan 29, 2007
BOSTON (MarketWatch) -- Schering-Plough Corp. posted a substantial jump in fourth-quarter earnings Monday on strong sales of Remicade and Nasonex, ... Free with registration - America's Intelligence Wire - AccessMyLibrary.com

Schering-Plough Seen Challenged By Generics in 2006  -  Jan 30, 2006
The analyst attributed the year-over-year gain to sales in Nasonex, PEG-Intron and Remicade. He also cited “sharply higher� equity income from the ... Forbes

… Published Study Demonstrates NASONEX(R) (Mometasone Furoate …  -  Dec 13, 2005
KENILWORTH, NJ, Dec. 13 /PRNewswire-FirstCall/ -- Results of a new study published in the December issue of the Journal of Allergy and Clinical Immunology ... Free with registration - PR Newswire - AccessMyLibrary.com

Press Release: NASONEX(R) Earns the Arthritis Foundation Ease-of-Use ...  -  Feb 28, 2007
NASONEX(R) Earns the Arthritis Foundation Ease-of-Use Commendation. from PR Newswire. Highbeam Research – FREE Trial. Pay-Per-View - PR Newswire - HighBeam Research

NASONEX(R) Now Approved in Japan for the Treatment of Allergic …  -  Jul 17, 2008
KENILWORTH, NJ, July 17 /PRNewswire-FirstCall/ -- Schering-Plough Corporation today announced that Schering-Plough KK, the company's country operation in ... RedOrbit

Data Show Nasal Congestion is Most Bothersome Symptom of Allergic …  -  Nov 8, 2005
According to an analysis of pooled data from four clinical studies presented at the meeting, NASONEX(R) (mometasone furoate monohydrate) provides effective ... Free with registration - PR Newswire - AccessMyLibrary.com

Nasonex--A Safe Option for Allergy Relief?  -  Oct 23, 2007
If you're considering using Nasonex to relieve your allergy symptoms you need to read this article. Nasonex is known as the only... ... Buzzle

Nasonex (Mometasone Furoate Monohydrate) Approved by Health …  -  Dec 6, 2006
POINTE-CLAIRE, QC, CANADA -- December 6, 2006 -- Schering Canada announced that Nasonex® (mometasone furoate monohydrate) has been approved by Health Canada ... DG News

Press Release: NASONEX(R) Now Approved in Japan for the Treatment …  -  Jul 17, 2008
NASONEX(R) Now Approved in Japan for the Treatment of Allergic Rhinitis in Adult Patients. from PR Newswire. Highbeam Research – FREE Trial. Pay-Per-View - PR Newswire - HighBeam Research

Respiratory Health; NASONEX now FDA-approved in United States for …  -  Jan 23, 2005
2005 JAN 23 - (NewsRx.com & NewsRx.net) -- Schering-Plough Corporation (NYSE: SGP) announced that the US Food and Drug Administration (FDA) has approved ... Pay-Per-View - Medical Letter on the CDC & FDA - Factiva, from Dow Jones

Schering-Plough Net Rises Fivefold on Vytorin, Zetia  -  Oct 20, 2006
Nasonex sales climbed 30 percent to $221 million and Clarinex rose 9 percent to $171 million. Sales of Schering's two hepatitis drugs, introduced in ... Bloomberg

NASONEX(R) Now Approved In Japan For The Treatment Of Allergic …  -  Jul 20, 2008
Schering-Plough Corporation (NYSE: SGP) announced that Schering-Plough KK, the company's country operation in Japan, has received marketing approval for ... Medical News Today - Medical News Today (press release)

NASONEX(R) Earns the Arthritis Foundation Ease-of-Use Commendation …  -  Feb 28, 2007
KENILWORTH, NJ, Feb. 28 /PRNewswire-FirstCall/ -- Schering-Plough today announced that the device used to deliver NASONEX(R) (mometasone furoate ... $4.95 - PR Newswire - ECNext

Scent-Free Nasonex(R) (Mometasone Furoate Monohydrate) Now …  -  Oct 20, 2006
POINTE-CLAIRE, QUEBEC, CANADA -- October 20, 2006 -- Nasonex® (mometasone furoate monohydrate), the number one doctor-prescribed nasal spray in Canada for ... DG News

… Patients With Allergic Rhinitis Prefer NASONEX(R) (Mometasone...  -  Sep 6, 2005
KENILWORTH, NJ, Sept. 6 /PRNewswire-FirstCall/ -- Schering-Plough Corporation today announced results of a head-to-head study comparing the scent and taste ... $4.95 - PR Newswire - ECNext

Nasonex: Most-Recalled TV Spot of 2007  -  Feb 27, 2008
The Nasonex bee, voiced by Antonio Banderas, was a popular fellow last year. The animated 30-second spot, bested the Rozerum beaver and Chantix's turtle and ... PharmExec.com

Respiratory Health; NASONEX now FDA-approved in United States for …  -  Jan 17, 2005
2005 JAN 17 - (NewsRx.com & NewsRx.net) -- Schering-Plough Corporation (NYSE: SGP) announced that the US Food and Drug Administration (FDA) has approved ... Pay-Per-View - Pharma Business Week - Factiva, from Dow Jones

FDA issues Flonase, Nasonex letters.(DIRECT MARKETING)  -  Jul 1, 2007
THE FDA'S Division of Drug Marketing, Advertising and Communications has issued untitled letters of violation to Schering-Plough for its Nasonex nasal spray ... Free with registration - Medical Marketing & Media - AccessMyLibrary.com

Nasonex [Archive] - Southern Maryland Community Forums  -  Mar 3, 2006
Anyone ever used it? I am on my second day and my nose is soooo sore, is this normal? Is this the one that is in a white bottle with green top? ... somd.com

Respiratory Health; NASONEX now FDA-approved in United States for …  -  Jan 19, 2005
2005 JAN 19 - (NewsRx.com & NewsRx.net) -- Schering-Plough Corporation (NYSE: SGP) announced that the US Food and Drug Administration (FDA) has approved ... Pay-Per-View - Immunotherapy Weekly - Factiva, from Dow Jones

Schering-Plough at Merrill Lynch Global Pharmaceutical, Biotechnology...  -  Feb 8, 2006
We also transformed NASONEX, increasing our prescription market share by 5 points. ... Let me highlight a few of those key brands, starting with NASONEX. ... Free with registration - Fair Disclosure Wire - AccessMyLibrary.com

Lunesta spots most recalled in study of DTC TV ads  -  Oct 24, 2007
4 Schering-Plough's Nasonex. Animated bee talks about prevention of nasal allergy symptoms while buzzing next to Nasonex bottle. (:30). Recall index 138. ... Medical Marketing & Media - Medical Marketing and Media

Earnings Calls: Schering Plough Earnings Call, Second Quarter 2008  -  Jul 22, 2008
In allergy, global NASONEX sales increased 6%, driven by solid growth across ... In the US, NASONEX sales declined 5%, driven by a mild spring allergy ... 123Jump.com

AAAAI: Once Daily Nasonex Good Enough for Pediatric Asthma  -  Mar 24, 2005
By Bruce Sylvester,. SAN ANTONIO, March 24-Once-a-day Nasonex (mometasone furoate) is as effective as twice-daily dosing in children with persistent asthma. ... MedPage Today

Schering-Plough at Goldman Sachs Annual Global Healthcare …  -  Jun 15, 2006
You can see that REMICADE, NASONEX, TEMODAR, and PEG-INTRON are making very strong ... On NASONEX, we transformed this 8-year-old product into the ... Free with registration - Fair Disclosure Wire - AccessMyLibrary.com

Nasonex.(drug overview)(Drug overview)  -  Dec 1, 2005
Nasonex nasal spray prevents and relieves the runny, stuffy nose that accompanies hay fever and year-round allergies. It contains a steroid medication that ... Free with registration - PDR Family Guide to Prescription Drugs - AccessMyLibrary.com

Do Consumers Understand Drug Ads?  -  May 16, 2008
Among DTC ad makers and drug companies, the Nasonex bee, created by ad ... (A version of the Nasonex bee ad was the most remembered new drug ad of 2007, ... TIME

Article: FDA issues Flonase, Nasonex letters.(DIRECT MARKETING) - …  -  Jul 1, 2007
FDA issues Flonase, Nasonex letters.(DIRECT MARKETING) ... find Medical Marketing & Media articles. THE FDA'S Division of Drug Marketing, Advertising and ... Pay-Per-View - Medical Marketing & Media - HighBeam Research

International Approvals: Solaraze, Nasonex, Advate  -  Dec 5, 2006
December 5, 2006 — Australia's Therapeutic Goods Administration has approved diclofenac sodium 3% gel for the management of actinic keratosis; Health Canada ... Medscape

… Published Study Demonstrates NASONEX(R) (Mometasone Furoate …  -  Dec 13, 2005
Newly Published Study Demonstrates NASONEX(R) (Mometasone Furoate Monohydrate) Effective for Nasal Polyps With Once- or Twice-Daily Dose. from PR Newswire. Pay-Per-View - PR Newswire - HighBeam Research

Are drug ads a waste of money?  -  Sep 2, 2008
Comparing sales of the arthritis med Enbrel, allergy spray Nasonex, ... A $194 million Enbrel campaign and $235 million Nasonex push failed to boost sales ... FiercePharma

Prescribing notes: Nasonex launches its new formulation.(Brief...  -  Jun 12, 2007
Nasonex (mometasone furoate) nasal spray has been reformulated to be alcohol-free. Schering-Plough claims scented alcohol in nasal sprays is a major cause ... $4.95 - Pharmacy Today - ECNext

… Patients With Allergic Rhinitis Prefer NASONEX(R) (Mometasone...  -  Sep 6, 2005
Research Shows Patients With Allergic Rhinitis Prefer NASONEX(R) (Mometasone Furoate Monohydrate) To Flonase(R) for Scent and Taste. from PR Newswire. Pay-Per-View - PR Newswire - HighBeam Research

Steroids for acute sinusitis  -  Apr 19, 2007
Steroid sprays like Flonase, Nasonex and Rhinocort, which work by reducing inflammation to promote drainage in the sinuses, are often prescribed to treat ... News-Medical.net

New formulation of Nasonex.(PRODUCTS)(Brief Article)  -  Apr 1, 2005
A scent-free, alcohol-free formulation of Nasonex (mometasone furoate monohydrate) nasal spray, 50 mcg, has been approved to help prevent most seasonal ... Free with registration - Internal Medicine News - AccessMyLibrary.com

Schering-Plough axes 1,100 jobs as it cuts down on manufacturing  -  Jun 8, 2006
The company said 550 regular full-time positions will be lost from its Manati site in Puerto Rico, which makes allergy nasal spray Nasonex and nasal ... In-PharmaTechnologist.com

Bellevue's singing bee teaches kids to cross the street  -  Sep 27, 2007
And, for an odder example, Nasonex (do bees gets colds? Am I missing something?). "It was originally going to be a centipede, but those got a little more ... nwsource.com

Study finds DTC ads not effective.  -  Oct 1, 2008
The study chose to look at three drugs: Enbrel, sold by Wyeth and Amgen; Zelnorm, sold by Novartis; and Nasonex, sold by Schering-Plough Corp. ... $9.94 - Response - Alacra Store

New formulation of Nasonex.(Products)(Brief Article)  -  Mar 1, 2005
A scent-free, alcohol-free formulation of Nasonex (mometasone furoate monohydrate) nasal spray, 50 mcg, has been approved to help prevent most seasonal ... Free with registration - Pediatric News - AccessMyLibrary.com

Nearly 20% of consumers frustrated with medication sites, Keynote...  -  May 17, 2006
The web site for Nasonex topped the web sites of three other leading allergy prescription drugs in consumers` opinion. 37% of site visitors said they were ... internetretailer.com

Drug ads: Big waste of money?  -  Sep 14, 2008
It focused on three drugs: Enbrel (for rheumatoid arthritis), Nasonex ... Prescription rates for Enbrel and Nasonex remained the same in both communities. ... $2.95 - The Telegraph - NewsBank

Nasonex.(FDA: actions in brief)(Brief Article)  -  Mar 1, 2005
FDA approved mometasone (Nasonex, Schering-Plough) for the treatment of nasal polyps in patients aged 18 years and older. Free with registration - Managed Healthcare Executive - AccessMyLibrary.com

New formulation of Nasonex.(PRODUCTS)(Brief Article) | Article from …  -  Apr 1, 2005
New formulation of Nasonex.(PRODUCTS)(Brief Article) ... find Internal Medicine News articles. A scent-free, alcohol-free formulation of Nasonex (mometasone ... Pay-Per-View - Internal Medicine News - HighBeam Research

Article: New formulation of Nasonex.(Products)(Brief Article) -...  -  Mar 1, 2005
New formulation of Nasonex.(Products)(Brief Article) ... find Pediatric News articles. A scent-free, alcohol-free formulation of Nasonex (mometasone furoate ... Pay-Per-View - Pediatric News - HighBeam Research

Schering-Plough Corp. - Chmn. & CEO Interview.  -  Jul 21, 2005
It`s this Nasonex, it`s the return of your allergy, Claritin-style business. ... And Nasonex is a great product. It just had not received the attention that ... Free with registration - Finance Wire - AccessMyLibrary.com

Article: New formulation of Nasonex.(PRODUCTS)(Brief Article) -...  -  Jul 1, 2005
New formulation of Nasonex.(PRODUCTS)(Brief Article) ... find Internal Medicine News articles. A scent-free, alcohol-free formulation of Nasonex (mometasone ... Pay-Per-View - Internal Medicine News - HighBeam Research

… -Plough Launches Scent-Free Formulation of NASONEX(R) in US - PR …  -  Jan 12, 2005
Schering-Plough Launches Scent-Free Formulation of NASONEX(R) in US from PR Newswire. Highbeam Research – FREE Trial. Pay-Per-View - PR Newswire - HighBeam Research

Press Release: NASONEX(R) (mometasone furoate monohydrate) …  -  Jun 29, 2005
NASONEX(R) (mometasone furoate monohydrate) Effective for Nasal Polyps with Once-Daily Dose. from PR Newswire. Highbeam Research – FREE Trial. Pay-Per-View - PR Newswire - HighBeam Research

New use for Schering-Plough's Nasonex.(Brief Article)  -  Jan 3, 2005
Schering-Plough's Nasonex (mometasone furoate monohydrate) Nasal Spray 50mcg has been cleared by the US Food and Drug Administration for the treatment of ... Pay-Per-View - Pharma Marketletter - Factiva, from Dow Jones

Schering-Plough's Nasonex "superior in scent and taste to GSK's ...  -  Sep 12, 2005
US drugmaker Schering-Plough says that results of a head-to-head study comparing the scent and taste of its allergic rhinitis nasal spray remedy Nasonex ... $4.95 - Pharma Marketletter - ECNext

Article: Scent-free Nasonex version ready.(Products)(Brief Article)( …  -  Aug 1, 2005
Scent-free Nasonex version ready.(Products)(Brief Article)(Advertisement) ... find Family Practice News articles. A scent-free, alcohol-free formulation of ... Pay-Per-View - Family Practice News - HighBeam Research

Once-Daily Inhaled Asthma Drug Wins FDA Approval  -  Apr 1, 2005
US in 1987 as the dermatologic ointment, Elocon (mometasone furoate ointment) and in 1997 as the nasal spray Nasonex (mometasone furoate monohydrate). ... Daily News Central

Press Release: NASONEX(R) (Mometasone Furoate Monohydrate) …  -  Jun 29, 2005
NASONEX(R) (Mometasone Furoate Monohydrate) Effective For Nasal Polyps With Once-Daily Dose. from PR Newswire Europe. Highbeam Research – FREE Trial. Pay-Per-View - PR Newswire Europe - HighBeam Research

Steroid-Free Astelin(R) Nasal Spray (R) Demonstrated Seasonal Allergy...  -  Feb 26, 2007
In addition, a group of patients treated with intranasal Nasonex(R) (mometasone furoate ... Both ASTELIN and Nasonex were well tolerated in the study. ... Medical News Today - Medical News Today (press release)

Ask the ad team  -  Aug 27, 2007
Q. Who's the voice of the animated bee in the Nasonex ad? A. Antonio Banderas. ... Nasonex maker Schering-Plough wouldn't name Banderas. ... Pay-Per-View - USA TODAY - ProQuest Archiver

收购开支影å“?å…ˆç?µè‘†é›…季利下é™?48%  -  Apr 23, 2008
...风湿性关节炎�物Remicade的季销售�增长36%,至5.07亿美元,过�症�物Nasonex的销售 涨8%,至3.07亿美元。Remicade由先�葆雅和强生制�(JNJ)��销售。 ... 浙江在线

Schering-Plough legt beim Gewinn deutlich zu  -  Jan 29, 2007
Dank hoher Absatzzahlen beim Rheumamittel Remicade und der Allergiearznei Nasonex sei das Ergebnis pro Aktie vor Sonderposten von sieben US-Cent im Vorjahr ... Handelsblatt

MedPointe:先ç?µè‘†é›…çš„Nasonex疗效ä¸?显著  -  Feb 27, 2007
...�MarketWatch伦敦2月26日讯】�有的MedPointe Pharmaceuticals进行的一项调查显示, 在八�时的试验阶段里,Astelin鼻喷雾器能够在任何时间内在使用�15分钟内解除花粉 ... 新浪网

… .- Un estudio muestra la eficacia de 'Nasonex' (Schering-Plough) en...  -  Oct 23, 2008
El uso del corticoide intranasal mometasona furoato, comercializado por Schering-Plough como 'Nasonex', en el tratamiento de la rinitis alérgica estacional ... ecodiario

Re: Nasonex oder Cetrizin /Hausstaubmilbenallergie  -  Aug 23, 2006
Nein Selbstmedi ist es nicht. Hat mir der Allergologe verschrieben. Asthma ist nicht vorhanden, es läuft mir einfach alles hinten runter und das löst ... QualiMedic

Nasonex in der Frühwangerschaft wegen Sinusitis?  -  Oct 10, 2008
...ich bin in der 4.5 SSW und habe eine Sinusitis und Polypen und eine Vernarbung am Eingang der linken Kieferhöhle. Ich war im Mai zur kompletten Nasen-Op mit ... QualiMedic

Winst Schering-Plough meer dan verdubbeld  -  Jul 23, 2007
De omzetgroei is met name te danken aan de groei van voorgeschreven medicijnen als Remicade (+28%), Nasonex (+22%) en Temodar (+26%). ... Trouw

Aarane und Nasonex bei Kinderwunsch  -  Jul 10, 2006
...im Moment nehme ich aufgrund einer Schimmelpilzallergie (die immer im Sommer auftritt) regelmäßig Nasonex und bei Bedarf Aarane. ... QualiMedic

å?ˆç›˜ï¼šå¤šåª’体ã€?å?Šå¯¼ä½“与硬件股领涨  -  Jul 24, 2007
...因Remicade与Nasonex�物畅销,该公�第二财季利润翻了一番以上。其季度�收与利润� 好于预期。 纳斯达克综�指数上涨了16.23点,至2703.83点,涨幅为0.60%;标准 ... 新浪网

Schering-Plough presteert beter dan verwacht  -  Apr 19, 2007
De omzetgroei is met name te danken aan de groei van voorgeschreven medicijnen als Remicade (+34%), Nasonex (+24%) en Temodar (+20%). ... Trouw

Nasonex in der Frühschwangerschaft?  -  Oct 8, 2008
...ich bin total verzweifelt. Habe meine Frage bereits in der Frauenarzt-Sprechstunde gestellt und wurde an Sie verwiesen. ... QualiMedic

… -Plough получила разрешение на маркетинг препарата Nasonex в Яп …  -  Jul 22, 2008
ПредполагаетÑ?Ñ?, что препарат поÑ?витÑ?Ñ? на фармрынке Японии оÑ?енью 2008 г. Ð’ наÑ?тоÑ?щее времÑ? Nasonex разрешен к применению в более чем 100 Ñ?транах по вÑ?ему миру. ФармацевтичеÑ?кий веÑ?тник

Schering-Plough Under Earnings Pressure From Generic Flonase  -  Mar 7, 2006
Nasonex is one of Schering-Plough's highest margin brands, ... The analyst maintained the 2007 Nasonex sales estimate of $580 million and said ... Forbes

Nasonex aprobado en España para tratar los pólipos nasales  -  Mar 29, 2005
La Agencia Española del Medicamento ha concedido a Nasonex (furoato mometasona monohidrato) la indicación para el tratamiento de pólipos nasales. ... doyma.es

Nasonex… Чем бы ни был заложен ноÑ?…  -  Oct 21, 2008
КитайÑ?кое креативное агентÑ?тво Euro RSCG Life разработало Ñ?ту Ñ?ерию принтов длÑ? компании Shering (в РоÑ?Ñ?ии Шеринг-Плау), котораÑ? выпуÑ?кает Ñ?прей длÑ? ноÑ?а ... Sostav.ru

… -Plough aumentó bº un 75% en 4TR por ventas de Remicade y Nasonex  -  Jan 29, 2007
Las ventas de Remicade aumentaron un 34% hasta 337 millones y las de Global Nasonex un 37% hasta 253 millones de dólares. elEconomista.es

Drug giants rapped over "cure" claims.  -  May 19, 2007
One of the drugs, Schering-Plough's Nasonex, is its second biggest selling product. ... Schering-Plough was also warned about suggesting that Nasonex could ... Free with registration - Sunday Business - AccessMyLibrary.com

Schering-Plough conform verwachting - DePers.nl  -  Jan 29, 2007
De omzetgroei is met name te danken aan de groei van voorgeschreven medicijnen als Remicade (+32%), Nasonex (+28%) en Temodar (+20%). ... DePers.nl

Article: Drug giants rapped over "cure" claims. - Sunday Business ( …  -  May 19, 2007
One of the drugs, Schering-Plough's Nasonex, is its second biggest selling product. ... Schering-Plough was also warned about suggesting that Nasonex could ... Pay-Per-View - Sunday Business - HighBeam Research

Sneezing Around The Water Cooler: Controlling Your Nasal Allergy …  -  Feb 16, 2007
NASONEX® is a nasal-inhaled steroid related to cortisol, a hormone produced naturally ... NASONEX reduces nasal congestion caused by an allergic reaction. ... $2.95 - Moffat County Morning News - NewsBank

Nasal spray vaccines may offer kids better flu protection | Article...  -  Mar 6, 2007
The Record (Bergen County, NJ); September 13, 2002 ; 304 words ...00-00-0000 Schering issues recall for Nasonex nasal spray By MICHELLE FAY CORTEZ ... Pay-Per-View - The Record - HighBeam Research

Article: Antacid use may weaken bones - The Record (Bergen County, NJ...  -  Jan 9, 2007
The Record (Bergen County, NJ); September 13, 2002 ; 304 words ...00-00-0000 Schering issues recall for Nasonex nasal spray By MICHELLE FAY CORTEZ ... Pay-Per-View - The Record - HighBeam Research

Steroid Spray Shrinks Nasal Polyps  -  Dec 15, 2005
The nasal steroid spray Nasonex was approved by the FDA for the treatment of nasal polyps a year ago this month, largely on the strength of the newly ... WebMD

Schering-Plough profit falls, but beats forecast  -  Jul 21, 2008
But she said US sales of several important company drugs, including Vytorin and intra-nasal allergy drug Nasonex, were somewhat disappointing. ... Reuters

What is the difference between Flonase and Veramyst?  -  Sep 2, 2008
I used it before the Nasonex. The doctor prescribed Veramyst because it treats ... Like I said I asked my doctor for Nasonex NOT Flonase so I can't see her ... HealthCentral.com

Schering-Plough at Merrill Lynch Global Pharmaceutical, Biotech &...  -  Sep 19, 2007
We've transformed our key products, like NASONEX and TEMODAR and PEG-INTRON. We drove the successful launch of VYTORIN starting in 2004. ... Free with registration - Fair Disclosure Wire - AccessMyLibrary.com

Fix It, Fred  -  Jan 17, 2008
At Schering it was Nasonex, a me-too allergy nose spray that had been ignored ... Nasonex, a nose spray, was better than its Claritin knockoff, Clarinex. ... Forbes

Merck, Schering-Plough Shares Up in 2Q  -  Jul 24, 2006
Kenilworth-based Schering-Plough, best known for its Nasonex spray and Clarinex pills for allergies, had one-time charges totaling $259 million in 2005's ... Washington Post

Ad stars: pharm exec honors the most innovative, creative, and...  -  Mar 1, 2007
BRAND Nasonex CLIENT Schering-Plough LEFT TO RIGHT: Ed Maslow, ... Enter the Nasonex Bee, a charming animated brand mascot with a suave celebrity accent and ... $4.95 - Pharmaceutical Executive - ECNext

Accounting Changes Send Schering-Plough to a Loss  -  Feb 13, 2008
Significant profit sources for Schering-Plough include the arthritis treatment Remicade and the allergy treatment Nasonex. Quarterly Remicade sales rose 35 ... New York Times

In- Depth Research on Schering-Plough Corp.  -  Apr 19, 2007
Its Prescription Pharmaceuticals segment offers NASONEX for nasal allergy ... Sales of Remicade jumped 34% to $373 million while Nasonex sales leaped 24% to ... Free with registration - M2 Presswire - AccessMyLibrary.com

Press Release: FDA Approves ASMANEX(R) (mometasone furoate) for …  -  Mar 31, 2005
Article: Newly Published Study Demonstrates NASONEX(R) (Mometasone ... ... Article: NASONEX(R) (mometasone furoate monohydrate) ... PR Newswire; June 29, ... Pay-Per-View - PR Newswire - HighBeam Research

Press Release: Data Show Nasal Congestion is Most Bothersome …  -  Nov 8, 2005
According to an analysis of pooled data from four clinical studies presented at the meeting, NASONEX(R) (mometasone furoate monohydrate) provides effective ... Pay-Per-View - PR Newswire - HighBeam Research

Nothing to Sneeze at: Generic Flonase Is Around the Corner, Along...  -  Mar 3, 2006
Despite a relatively crowded inhaled steroid category that includes popular drugs such as Nasonex and Nasacort, annual US sales of Flonase are close to $1 ... Pay-Per-View - Drug Benefit News - Factiva, from Dow Jones

Schering-Plough reports lower profit - MarketWatch  -  Oct 21, 2008
Also rising were sales of its brain-cancer therapy Temodar and allergy medication Nasonex. Temodar sales leapt 27% to $273 million, while Nasonex rose 6% to ... MarketWatch

Q4 2006 Schering-Plough Earnings Conference Call - Final.  -  Jan 29, 2007
We transformed NASONEX into a product that is approaching the $1 billion annual sales mark ... NASONEX is protected. Other important products are protected. ... Free with registration - Fair Disclosure Wire - AccessMyLibrary.com

Stocks Get Lift From Fed News; Shares also rise on upbeat profits as ...  -  Oct 25, 2005
Rival Schering-Plough added 2 cents to $21.13 after its profit tripled in the third quarter from strong product sales, including the allergy drug Nasonex. ... Pay-Per-View - Los Angeles Times - ProQuest Archiver

Vytorin Weighs on Schering's Profit Beat  -  Jul 21, 2008
Nasonex sales increased 6%, with rising international sales offsetting a decline in US revenue. Sales of brain tumor treatment Tremador increased 16% to ... TheStreet.com - TheStreet.com (subscription)

Q4 2006 Schering-Plough Earnings Conference Call - Part 1.  -  Jan 2, 2007
We transformed NASONEX into a product that is approaching the $1 billion annual sales mark ... NASONEX is protected. Other important products are protected. ... Free with registration - America's Intelligence Wire - AccessMyLibrary.com

Value of direct-to-consumer drug advertising oversold  -  Mar 9, 2008
They found that for two of the drugs, Enbrel and Nasonex, DTCA had no effect ... For Enbrel and Nasonex, there are a number of over-the-counter and ... innovations report

New indications.(Rx)  -  Jan 10, 2005
Used once or twice daily, Nasonex reduces the polyps, relieves symptoms, ... Nasonex was already approved for the nasal symptoms of seasonal allergic and ... Free with registration - Drug Topics - AccessMyLibrary.com

Allergy alarm: what with seasonal demand, over-the-counter switches,...  -  Apr 1, 2006
Unlike Flonase, Schering-Plough's Nasonex (mometasone furoate monohydrate), ... Nasonex buzzed into the consciousness of the American public in 2005 on the ... Free with registration - Medical Marketing & Media - AccessMyLibrary.com

Brand Names/Synonyms:
Nasonex is also known by the following brand names and/or synonymsAsmanex Twisthaler; Combisor; Elocom; Elocon; Mometasone; Mometasone Furoate; Nasonex

Drug Category:
Nasonex is categorized under the following by the FDA: Anti-allergic Agents; Anti-inflammatory Agents; ATC:D07AC13; ATC:D07XC03;

Dosage Forms:
CREAM; LOTION; METERED-DOSE (PUMP); OINTMENT

Absorption:
Nasal spray is virtually undetectable in plasma

Interactions:
[an error occurred while processing this directive]



Chemical IUPAC Name:
9-chloro-17-(2-chloroacetyl)-11,17-dihydroxy-10,13,16-trimethyl-6,7,8, 11,12,





Health Home | Conditions | Cancer | Medications | Surgery | Vaccines


The Cancer News Network


Disclaimer:

Contact a physician with regard to health concerns. Email requests for further health information will be discarded.

The materials contained on this Web site are for informational purposes only and do not constitute health or medical advice. Use of information on this site does not create or constitute any kind of agreement or contract between you and the owners or users of this site, the owners of the servers upon which it is housed, or anyone else who is in any way connected with this site.

Many links on cancernewsnetwork.org lead to other sites. cancernewsnetwork.org does not sponsor, endorse or otherwise approve of the materials appearing in such sites. Nor is CancerNewsNetwork.org responsible for dead or misdirected links.

IF YOU NEED A LINK OR TEXT REMOVED FROM THIS PAGE PLEASE CONTACT cancernewsnetwork (at) live.com.
We will do our best to accommodate your request.



COPYRIGHT 2009 CANCERNEWSNETWORK | Privacy